loading
전일 마감가:
$21.58
열려 있는:
$21.53
하루 거래량:
161.67K
Relative Volume:
0.22
시가총액:
$1.73B
수익:
$305.00K
순이익/손실:
$-328.98M
주가수익비율:
-5.5398
EPS:
-3.83
순현금흐름:
$-309.60M
1주 성능:
+8.87%
1개월 성능:
+15.51%
6개월 성능:
+69.03%
1년 성능:
-10.08%
1일 변동 폭
Value
$21.18
$21.92
1주일 범위
Value
$18.86
$21.92
52주 변동 폭
Value
$9.90
$27.20

Viridian Therapeutics Inc Stock (VRDN) Company Profile

Name
명칭
Viridian Therapeutics Inc
Name
전화
617.272.4600
Name
주소
221 CRESCENT STREET, WALTHAM
Name
직원
143
Name
트위터
Name
다음 수익 날짜
2024-11-11
Name
최신 SEC 제출 서류
Name
VRDN's Discussions on Twitter

VRDN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
VRDN
Viridian Therapeutics Inc
21.22 1.76B 305.00K -328.98M -309.60M -3.83
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
406.28 100.41B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
608.20 59.59B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
459.93 59.77B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
770.44 45.14B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
343.55 37.42B 3.81B -644.79M -669.77M -6.24

Viridian Therapeutics Inc Stock (VRDN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-08-25 재개 Jefferies Buy
2024-12-19 다운그레이드 Wells Fargo Overweight → Equal Weight
2024-11-25 개시 TD Cowen Buy
2024-09-11 재확인 Needham Buy
2024-06-11 개시 Wolfe Research Outperform
2024-06-06 개시 Goldman Buy
2024-05-09 다운그레이드 B. Riley Securities Buy → Neutral
2024-05-09 다운그레이드 Ladenburg Thalmann Buy → Neutral
2023-06-14 개시 BTIG Research Buy
2023-06-14 재개 Credit Suisse Outperform
2023-05-30 개시 RBC Capital Mkts Outperform
2023-04-17 개시 Wells Fargo Overweight
2023-03-30 개시 Stifel Buy
2022-12-19 개시 Cowen Outperform
2022-12-19 개시 Needham Buy
2022-12-16 개시 Credit Suisse Outperform
2022-12-01 개시 H.C. Wainwright Buy
2022-06-23 개시 B. Riley Securities Buy
2021-11-18 개시 SVB Leerink Outperform
2021-10-12 개시 Evercore ISI Outperform
2021-01-25 개시 Ladenburg Thalmann Buy
모두보기

Viridian Therapeutics Inc 주식(VRDN)의 최신 뉴스

pulisher
06:00 AM

Real time alert setup for Viridian Therapeutics Inc. performanceLong Setup & Technical Entry and Exit Alerts - newser.com

06:00 AM
pulisher
Sep 30, 2025

How Viridian Therapeutics Inc. stock reacts to bond yields2025 Year in Review & Technical Confirmation Trade Alerts - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

Is Viridian Therapeutics Inc. (1S1) stock protected from inflationWeekly Trade Review & Safe Entry Momentum Stock Tips - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga

Sep 29, 2025
pulisher
Sep 29, 2025

Is Viridian Therapeutics Inc. stock dividend yield sustainableJuly 2025 Update & High Yield Stock Recommendations - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Will Viridian Therapeutics Inc. (1S1) stock beat growth indexesWeekly Stock Summary & Safe Swing Trade Setup Alerts - newser.com

Sep 29, 2025
pulisher
Sep 28, 2025

Is Viridian Therapeutics Inc a good long term investmentHigh Frequency Trading Trends & In-Depth Analyst Ratings Explained Simply - earlytimes.in

Sep 28, 2025
pulisher
Sep 27, 2025

Is Viridian Therapeutics Inc. stock safe for conservative investors2025 Performance Recap & Real-Time Volume Analysis - newser.com

Sep 27, 2025
pulisher
Sep 26, 2025

Viridian Therapeutics: De-Risked Leadership In Thyroid Eye Disease (NASDAQ:VRDN) - Seeking Alpha

Sep 26, 2025
pulisher
Sep 23, 2025

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Receives $37.78 Consensus Target Price from Analysts - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: Potential 93.73% Upside Amid Promising Clinical Trials - DirectorsTalk Interviews

Sep 23, 2025
pulisher
Sep 21, 2025

A Look at Viridian Therapeutics’s Valuation Following Completion of Pivotal Phase III Trial Enrollment for VRDN-003 - Sahm

Sep 21, 2025
pulisher
Sep 20, 2025

Dividend Watch: Can Viridian Therapeutics Inc. expand its profit marginsMarket Movers & Consistent Profit Focused Trading Strategies - خودرو بانک

Sep 20, 2025
pulisher
Sep 19, 2025

Insider Trends: Is Viridian Therapeutics Inc stock a good pick for beginnersJobs Report & AI Optimized Trade Strategies - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Is Viridian Therapeutics Inc. forming a reversal pattern2025 Year in Review & Momentum Based Trading Ideas - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Will Viridian Therapeutics Inc benefit from geopolitical trendsJuly 2025 EndofMonth & High Win Rate Trade Tips - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

VIX Spike: Should I hold or sell Viridian Therapeutics Inc nowTrade Ideas & Consistent Return Investment Signals - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Aug Big Picture: What is Viridian Therapeutics Incs 5 year growth outlookEarnings Recap Report & AI Enhanced Trading Signals - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Building trade automation scripts for Viridian Therapeutics Inc.Market Risk Summary & Technical Buy Zone Confirmations - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Quarterly Trades: Will Viridian Therapeutics Inc benefit from geopolitical trendsWeekly Trend Summary & Fast Entry Momentum Alerts - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

VIX Spike: What is Viridian Therapeutics Incs 5 year growth outlookSwing Trade & Technical Pattern Based Signals - khodrobank.com

Sep 19, 2025
pulisher
Sep 18, 2025

Is Viridian Therapeutics Inc. meeting your algorithmic filter criteriaJuly 2025 Sector Moves & Real-Time Market Sentiment Alerts - newser.com

Sep 18, 2025
pulisher
Sep 18, 2025

Detecting support and resistance levels for Viridian Therapeutics Inc.Trade Entry Report & Step-by-Step Swing Trade Plans - newser.com

Sep 18, 2025
pulisher
Sep 17, 2025

Viridian Therapeutics Inc. stock prediction for this weekWeekly Stock Summary & Community Consensus Stock Picks - newser.com

Sep 17, 2025
pulisher
Sep 17, 2025

Risk Analysis: What is the target price for Viridian Therapeutics Inc stockPrice Action & Reliable Breakout Forecasts - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

Published on: 2025-09-17 20:01:22 - خودرو بانک

Sep 17, 2025
pulisher
Sep 16, 2025

Does Viridian Therapeutics Inc. qualify in momentum factor screeningQuarterly Performance Summary & High Accuracy Swing Entry Alerts - newser.com

Sep 16, 2025
pulisher
Sep 16, 2025

Hedge Fund Bets: What is CGONs 5 year growth outlookSwing Trade & Fast Entry High Yield Stock Tips - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Aug Wrap: Should I add Viridian Therapeutics Inc. stock to my portfolio2025 Bull vs Bear & Proven Capital Preservation Methods - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

BTIG reiterates Buy rating on Viridian Therapeutic stock as trials complete enrollment - Investing.com Canada

Sep 16, 2025
pulisher
Sep 16, 2025

Breakouts Watch: Can Viridian Therapeutics Inc withstand a market correctionWeekly Investment Recap & Fast Gain Stock Tips - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Decliners Report: Can Viridian Therapeutics Inc. disrupt its industry2025 Stock Rankings & Low Risk High Reward Trade Ideas - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Viridian Therapeutics, Inc. $VRDN Shares Sold by Alliancebernstein L.P. - MarketBeat

Sep 16, 2025
pulisher
Sep 16, 2025

Weekly Recap: What are the future prospects of Viridian Therapeutics IncJuly 2025 Action & Free High Accuracy Swing Entry Alerts - خودرو بانک

Sep 16, 2025
pulisher
Sep 15, 2025

Viridian Therapeutics: Promising Pipeline and Strategic Advancements Justify Buy Rating - TipRanks

Sep 15, 2025
pulisher
Sep 15, 2025

Viridian Therapeutics Announces Completion of Enrollment in both REVEAL Clinical Trials and Positive Portfolio Updates - BioSpace

Sep 15, 2025
pulisher
Sep 15, 2025

Entry Recap: Can Viridian Therapeutics Inc. lead its sector in growthQuarterly Investment Review & Expert Approved Momentum Trade Ideas - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Momentum Shift: Is BCGWW undervalued by DCF analysisJuly 2025 Reactions & Low Drawdown Momentum Ideas - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Published on: 2025-09-15 21:50:00 - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Viridian Therapeutics completes enrollment in REVEAL-1 and REVEAL-2 clinical trials for VRDN-003 - Ophthalmology Times

Sep 15, 2025
pulisher
Sep 15, 2025

Viridian Therapeutics announces completion of enrollment in both Reveal clinical trials and positive portfolio updates - MarketScreener

Sep 15, 2025
pulisher
Sep 15, 2025

Viridian Therapeutics Announces Completion Of Enrollment In Both Reveal Clinical Trials And Positive Portfolio Updates - TradingView

Sep 15, 2025
pulisher
Sep 15, 2025

Viridian Therapeutics (VRDN) Completes Enrollment for Key Phase 3 Trials - GuruFocus

Sep 15, 2025
pulisher
Sep 15, 2025

Hedge Fund Bets: Can Viridian Therapeutics Inc. expand its profit margins2025 Top Decliners & Daily Volume Surge Signals - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Octagon Capital Advisors LP Reduces Stake in Viridian Therapeutics, Inc. $VRDN - MarketBeat

Sep 15, 2025
pulisher
Sep 14, 2025

Exome Asset Management LLC Invests $2.93 Million in Viridian Therapeutics, Inc. $VRDN - MarketBeat

Sep 14, 2025
pulisher
Sep 12, 2025

Yiheng Capital Management L.P. Cuts Stock Position in Viridian Therapeutics, Inc. $VRDN - MarketBeat

Sep 12, 2025
pulisher
Sep 12, 2025

Adage Capital Partners GP L.L.C. Sells 555,414 Shares of Viridian Therapeutics, Inc. $VRDN - MarketBeat

Sep 12, 2025
pulisher
Sep 11, 2025

Invesco Ltd. Acquires 14,672 Shares of Viridian Therapeutics, Inc. $VRDN - MarketBeat

Sep 11, 2025

Viridian Therapeutics Inc (VRDN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$35.83
price up icon 1.66%
$85.75
price up icon 1.10%
$31.38
price up icon 2.25%
$102.62
price up icon 4.05%
$144.22
price up icon 0.15%
biotechnology ONC
$342.98
price up icon 0.67%
자본화:     |  볼륨(24시간):